Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 25,000 shares at $19.04 ($477K) on 2023-01-06, disclosed to the SEC on 2023-01-09.
Open-market sale of $477k PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.04 | 15,000 | $286K | 59.8% |
| 2 | $19.17 | 5,000 | $96K | 20.1% |
| 3 | $19.17 | 5,000 | $96K | 20.1% |
| Total | $19.09 avg | 25,000 | $477K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |